NDC 70112-155

LevigoSP

Lidocaine/benzalkoium Chloride Spray

LevigoSP is a Topical Spray in the Human Otc Drug category. It is labeled and distributed by Topicare Management, Llc. The primary component is Lidocaine Hydrochloride; Benzalkonium Chloride.

Product ID70112-155_6530ab28-1030-0364-e053-2991aa0a208b
NDC70112-155
Product TypeHuman Otc Drug
Proprietary NameLevigoSP
Generic NameLidocaine/benzalkoium Chloride Spray
Dosage FormSpray
Route of AdministrationTOPICAL
Marketing Start Date2018-03-01
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart348
Labeler NameTopicare Management, LLC
Substance NameLIDOCAINE HYDROCHLORIDE; BENZALKONIUM CHLORIDE
Active Ingredient Strength3 mg/mL; mg/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70112-155-08

240 mL in 1 BOTTLE, SPRAY (70112-155-08)
Marketing Start Date2018-03-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70112-155-08 [70112015508]

LevigoSP SPRAY
Marketing CategoryOTC monograph not final
Application Numberpart348
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-03-08

NDC 70112-155-05 [70112015505]

LevigoSP SPRAY
Marketing CategoryOTC monograph not final
Application Numberpart348
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2018-03-19

Drug Details

Active Ingredients

IngredientStrength
BENZALKONIUM CHLORIDE.13 mg/mL

OpenFDA Data

SPL SET ID:67cb2d7f-47a0-c7e8-e053-2991aa0a1951
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.